HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Positron emission tomographic studies of dopa-responsive dystonia and early-onset idiopathic parkinsonism.

Abstract
There are two major syndromes presenting in the early decades of life with dystonia and parkinsonism: dopa-responsive dystonia (DRD) and early-onset idiopathic parkinsonism (EOIP). DRD presents predominantly in childhood with prominent dystonia and lesser degrees of parkinsonism. EOIP presents before age 40 with parkinsonism (often with associated dystonia). Both disorders are exquisitely sensitive to levodopa, although the long-term prognosis in each appears to be different. Some have suggested, however, that DRD is a form of EOIP. We performed positron emission tomography with 6-fluoro-dopa in 10 patients with DRD and 18 patients with EOIP to study the integrity of their nigrostriatal dopaminergic systems. In DRD, we found normal striatal FD uptake. In contrast, patients with EOIP had reduced striatal FD uptake. We conclude that the patho-physiologies of DRD and EOIP are distinct. Although both disorders presumably represent a deficiency of striatal dopamine, the results suggest that in DRD dopa uptake, decarboxylation, and storage mechanisms are intact. This may explain the sustained response of DRD to low doses of levodopa. 6-Fluoro-dopa positron emission tomography distinguishes DRD from EOIP.
AuthorsB J Snow, T G Nygaard, H Takahashi, D B Calne
JournalAnnals of neurology (Ann Neurol) Vol. 34 Issue 5 Pg. 733-8 (Nov 1993) ISSN: 0364-5134 [Print] United States
PMID8239569 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Fluorine Radioisotopes
  • fluorodopa F 18
  • Levodopa
  • Dihydroxyphenylalanine
Topics
  • Adolescent
  • Adult
  • Corpus Striatum (diagnostic imaging)
  • Diagnosis, Differential
  • Dihydroxyphenylalanine (analogs & derivatives)
  • Dystonia (diagnostic imaging, drug therapy)
  • Female
  • Fluorine Radioisotopes
  • Humans
  • Levodopa (therapeutic use)
  • Male
  • Middle Aged
  • Parkinson Disease (diagnostic imaging, drug therapy)
  • Prognosis
  • Tomography, Emission-Computed

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: